Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Oxybutynin in Pediatric Neurogenic Bladder
NCT01716624Phase 3Completed
- Start
- May 2011
- Primary completion
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in neurogenic bladder. Started May 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on NCT01716624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01716624.